Pancreatic Cancer Research

ResearcherUNSW SydneyActive in the last 2 years

Koroush Shahsavar Haghighi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3834-463X; OpenAlex author ID A5014681581. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
51
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 3 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers · 2026: 3 papers

Papers 13

  1. HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer. Co-author DOI 10.1038/s41388-026-03865-y↗
  2. βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer. Co-author DOI 10.1038/s41419-026-08657-6↗
  3. Neoadjuvant chemotherapy induces transient, regimen-specific immune–stromal reprogramming in pancreatic ductal adenocarcinoma Co-author DOI 10.64898/2026.09.07.749769↗
  4. MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability. Co-author DOI 10.1016/j.neo.2025.101138↗
  5. Aiming for high quality of care for completed resections and improved margin status in pancreatic cancer surgery. Co-author DOI 10.1016/j.pan.2025.09.029↗
  6. βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer Co-author DOI 10.1101/2022.09.29.510034↗
  7. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities. Co-author DOI 10.3390/cancers14102539↗
  8. Computed Tomography Radiomics Signatures: Sensitive biomarkers for clinical decision support in pancreatic cancer- a pilot study Co-author DOI 10.1101/2021.12.03.21267217↗
  9. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition. Co-author DOI 10.1158/0008-5472.can-20-2496↗
  10. Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer? Co-author DOI 10.3390/cancers13102427↗
  11. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. Co-author DOI 10.1016/j.hpb.2018.08.016↗
  12. Centralising care for patients with pancreatic cancer: a hybrid model approach. First author DOI 10.5694/mja16.00903↗
  13. Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus. Co-author DOI 10.5694/mja16.00061↗

Closest collaborators

The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Goldstein · 9 shared papers, 2016–2026 · strength 1.19
  2. Phoebe A. Phillips · 7 shared papers, 2021–2026 · strength 1.12
  3. Joshua A. McCarroll · 6 shared papers, 2021–2026 · strength 0.93
  4. George Sharbeen · 6 shared papers, 2021–2026 · strength 0.93
  5. John Kokkinos · 6 shared papers, 2021–2026 · strength 0.93
  6. Amber L. Johns · 5 shared papers, 2021–2026 · strength 0.79
  7. Mert Erkan · 5 shared papers, 2021–2026 · strength 0.79
  8. Anthony James Gill · 5 shared papers, 2021–2026 · strength 0.79
  9. Val Gebski · 5 shared papers, 2021–2026 · strength 0.72
  10. Jennifer P. Morton · 4 shared papers, 2021–2026 · strength 0.59
  11. Marina Pajic · 4 shared papers, 2021–2026 · strength 0.58
  12. Jaswinder Singh Samra · 4 shared papers, 2016–2025 · strength 0.47
  13. Australian Pancreatic Cancer Genome Initiative · 2 shared papers, 2025–2026 · strength 0.39
  14. James G. Kench · 3 shared papers, 2016–2025 · strength 0.34
  15. Minoti Vivek Apte · 2 shared papers, 2021–2026 · strength 0.29
  16. Paul Timpson · 2 shared papers, 2021–2026 · strength 0.29
  17. Rachel Ε. Neale · 2 shared papers, 2019–2025 · strength 0.27
  18. Ashika D. Maharaj · 2 shared papers, 2019–2025 · strength 0.27
  19. John Raymond Zalcberg · 2 shared papers, 2019–2025 · strength 0.27
  20. Neil Donald Merrett · 2 shared papers, 2019–2025 · strength 0.27
  21. Liane Ioannou · 2 shared papers, 2019–2025 · strength 0.27
  22. Charles H. C. Pilgrim · 2 shared papers, 2019–2025 · strength 0.27
  23. Sue Evans · 2 shared papers, 2019–2025 · strength 0.27
  24. Kate White · 2 shared papers, 2019–2025 · strength 0.27
  25. Daniel Gerald Croagh · 2 shared papers, 2019–2025 · strength 0.27

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.